A Test in Context: Neprilysin: Function, Inhibition, and Biomarker

Area of Science:

• Biochemistry and Molecular Biology
• Cardiovascular Research
• Pharmacology

Background:

• Neprilysin is a widely distributed zinc-dependent endopeptidase with numerous peptide substrates.
• Its diverse functions and involvement in various physiological processes are increasingly recognized.
• Understanding neprilysin's role is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To review the genetic, structural, substrate, and pathophysiological aspects of neprilysin.
• To evaluate neprilysin as a therapeutic target and the clinical utility of its inhibitors.
• To assess soluble neprilysin as a potential biomarker in heart failure patients.

Main Methods:

• Comprehensive review of literature, including genetically modified models.
• Analysis of pre-clinical and clinical data on synthetic neprilysin inhibitors.
• Examination of studies investigating soluble neprilysin as a biomarker.

Main Results:

• Neprilysin exhibits broad substrate specificity and significant pathophysiological relevance.
• Synthetic neprilysin inhibitors show promise, particularly in combination with renin-angiotensin system antagonists.
• Soluble neprilysin demonstrates potential as a biomarker surrogate in heart failure.

Conclusions:

• Neprilysin is a validated and significant therapeutic target in cardiovascular medicine.
• Further research is needed to establish soluble neprilysin's clinical utility as a biomarker.
• Neprilysin inhibitors represent a valuable therapeutic avenue, especially for heart failure management.